Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY: LH )

246.49 +1.62 (+0.66%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 565,909
Open 245.14
Bid (Size) 221.11 (2)
Ask (Size) 253.61 (1)
Prev. Close 244.87
Today's Range 244.84 - 248.60
52wk Range 191.97 - 258.59
Shares Outstanding 83,700,000
Dividend Yield 1.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
Labcorp's Q4 EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma. 
Via Benzinga
Labcorp (NYSE:LH) Surprises With Q4 Sales, Full-Year Outlook Slightly Exceeds Expectations
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.8% year on year to $3.33 billion. The company’s full-year revenue... 
Via StockStory

Performance

YTD
+8.02%
+8.02%
1 Month
+3.23%
+3.23%
3 Month
+3.29%
+3.29%
6 Month
+8.99%
+8.99%
1 Year
+13.78%
+13.78%

More News

Read More
Earnings Scheduled For February 6, 2025
Via Benzinga
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
Via StockStory
Beyond The Numbers: 6 Analysts Discuss Labcorp Holdings Stock
Via Benzinga
Beyond The Numbers: 8 Analysts Discuss Labcorp Holdings Stock
Via Benzinga
Analyst Expectations For Labcorp Holdings's Future
Via Benzinga
Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts
Via Benzinga
Analyst Ratings For Labcorp Holdings
Via Benzinga
Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Via Benzinga
Topics Government
Exposures Political
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
From Praia Health
Via Business Wire
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
Via Benzinga
Topics Earnings
Exposures Financial
Analyst Expectations For Labcorp Holdings's Future
Via Benzinga
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Via Benzinga
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Via Benzinga
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
From NOWDiagnostics, Inc.
Via Business Wire
Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Labcorp Holdings
Via Benzinga
Analyst Ratings For Laboratory Corp
Via Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Via Benzinga
Is This Telehealth Stock a Buy After the Recent Pullback?
Via MarketBeat
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.